Colin T. Dourish

Best Publications

• Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

  Jon K. Shepherd;Savraj S. Grewal;Allan Fletcher;David J. Bill

  813
  Citations

• Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.

  Allan Fletcher;Elaine A. Forster;David J. Bill;Geraldine Brown

  593
  Citations

• Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.

  C. T. Dourish;P. H. Hutson;G. Curzon

  367
  Citations

• Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice.

  Steven P. Vickers;Peter G. Clifton;Colin T. Dourish;Laurence H. Tecott

  366
  Citations

• The role of CCK caerulein, and CCK antagonists in nociception.

  Nigel Scott Baber;Colin Trevor Dourish;David Robert Hill

  328
  Citations

• The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.

  C.T. Dourish;M.F. O'Neill;J. Coughlan;S.J. Kitchener

  322
  Citations

• Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

  S. P. Vickers;L. J. Webster;A. Wyatt;C. T. Dourish

  321
  Citations

• Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.

  CT Dourish;W Rycroft;SD Iversen

  305
  Citations

• Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents

  Allan Fletcher;Ian A. Cliffe;Colin T. Dourish

  270
  Citations

• Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.

  G.A. Kennett;C.T. Dourish;G. Curzon

  267
  Citations

• Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.

  Steven P Vickers;Colin T Dourish;Guy A Kennett

  256
  Citations

• Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder

  Bryan H. King;D. Mark Wright;Benjamin L. Handen;Linmarie Sikich

  246
  Citations

• Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.

  P.H. Hutson;C.T. Dourish;G. Curzon

  246
  Citations

• Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety

  S.M Weiss;G Wadsworth;A Fletcher;C.T Dourish

  244
  Citations

• Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718

  Colin T. Dourish;Diane Hawley;Susan D. Iversen

  224
  Citations

• 5-HT1B agonists induce anorexia at a postsynaptic site.

  G.A. Kennett;C.T. Dourish;G. Curzon

  216
  Citations

• Cholecystokinin and anxiety

  S. Ravard;C.T. Dourish

  199
  Citations

• Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).

  C.T. Dourish;P.H. Hutson;G. Curzon

  198
  Citations

• 8-OH-DPAT-induced hyperphagia: Its neural basis and possible therapeutic relevance

  C.T. Dourish;P.H. Hutson;G.A. Kennett;G. Curzon

  197
  Citations

• Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action.

  G.A. Kennett;M. Marcou;C.T. Dourish;G. Curzon

  195
  Citations